LithuanaBIO and life sciences companies took part in BIO-Europe 2024, 4-6 November

LithuaniaBIO together with Innovation agency and Lithuanian life science companies had a remarkable presence at BIO-Europe 2024 in Stockholm, Sweden. Representing our country with a national stand, we showcased the vibrant and innovative Lithuanian life science sector. At the event, Lithuanian innovators from Genie Biotech, Cureline Baltic, Vital3D Technologies, Biomatter, EXOLITUS, Caszyme, LAIMA, Profarma, VUGENE,…

Details

VU Faculty of Medicine’s Medical Science Center opening

In Vilnius, at the Santara Valley, the VU Faculty of Medicine’s Medical Science Center was opened! This is the largest investment in medical science infrastructure in independent Lithuania The new Medical Science Center houses unique laboratories and research centers. It will utilize various tools – from human cell cultivation and modern molecular research to digital…

Details

“Lithuanian Life Sciences Founders’ Conference 2024” took place on 18 September

On September 18, the “Lithuanian Life Sciences Co-Creators Conference 2024” took place! The event brought together the biggest leaders in the life sciences sector. During the event, we listened to interesting and inspiring presentations and discussions about the sector’s current issues, retrospectives, and future visions. This discussion included participation from LithuaniaBIO President Tomas Andrejauskas and…

Details

Biomatter raises a €6.5 million seed round to unlock the power of generative AI for enzyme design

Biomatter, a leading enzyme design company, has successfully closed a €6.5 million seed funding round jointly led by Inventure and UVC Partners. In 2019 Biomatter unveiled the first fully functional enzymes created with generative AI in Nature Machine Intelligence. This was a paramount milestone for the synthetic biology field, spawning multiple new research and development…

Details

Loading